MainBusinessBiotechnology and PharmaceuticalsPharmaceuticals › SciClone Pharmaceuticals, Inc.

SciClone Pharmaceuticals, Inc.

Edit Page
Report
Scan day: 12 February 2014 UTC
7
Virus safety - good
Description: Develops and markets products targeted for treatment of cancer and diseases such as hepatitis B and C, cystic fibrosis and immune system disorders. Based in San Mateo, California. (Nasdaq: SCLN)
SciClone is a US-based, China-focused specialty pharmaceutical company with a substantial revenue-generating and profitable commercial business and a broad, marketed product portfolio of differentiated therapies for oncology, infectious diseases and cardiovascular disorders.
Size: 275 chars

Contact Information

Email:
Phone&Fax:
Address:
Extended:

WEBSITE Info

Page title:SciClone Pharmaceuticals
Keywords:
Description:
IP-address:208.88.78.6

WHOIS Info

NS
Name Server: ADNS.CS.SITEPROTECT.COM
Name Server: BDNS.CS.SITEPROTECT.COM
WHOIS
Status: clientTransferProhibited
Date
Creation Date: 08-sep-1997
Expiration Date: 07-sep-2017